Synovial fluid analysis for diagnosis of intercritical gout

…, A Martínez, J Rosas, P Vela - Annals of Internal …, 1999 - acpjournals.org
Background: The diagnosis of gout in the intercritical phase can be difficult. Objective: To
determine whether synovial fluid analysis allows the diagnosis of intercritical gout. Design: …

Tocilizumab in giant cell arteritis: multicenter open-label study of 22 patients

…, J Narváez, A Sánchez-Andrade, P Vela… - Seminars in arthritis and …, 2015 - Elsevier
Objective To assess the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) patients with
refractory disease and/or with unacceptable side effects due to corticosteroids. Methods A …

Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

…, P Lluch, S Manrique-Arija, P Vela… - Seminars in arthritis and …, 2019 - Elsevier
Objective: Tocilizumab (TCZ) has shown efficacy in clinical trials on giant cell arteritis (GCA).
Real-world data are scarce. Our objective was to assess efficacy and safety of TCZ in …

Silent monosodium urate crystal deposits are associated with severe coronary calcification in asymptomatic hyperuricemia: an exploratory study

…, J Sánchez‐Payá, E Pascual, P Vela… - Arthritis & …, 2016 - Wiley Online Library
Objective To evaluate the association between monosodium urate (MSU) crystal deposits in
patients with asymptomatic hyperuricemia and the severity and extension of coronary artery …

Case series of acute arthritis during COVID-19 admission

…, V Boix, J Gil, E Merino, P Vela… - Annals of the …, 2021 - ard.bmj.com
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
changed life significantly worldwide. Rheumatologists also had to get used to the new context, …

[HTML][HTML] Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

…, JL Andreu, MÁ Aguirre-Zamorano, P Vela… - Arthritis research & …, 2018 - Springer
Background Systemic lupus erythematosus (SLE) is a common systemic autoimmune
disease with a complex genetic inheritance. Genome-wide association studies (GWAS) have …

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis …

…, J Sanz-Sanz, FJ de Toro-Santos, P Vela… - …, 2015 - academic.oup.com
Objective. The aim of this study was to establish guidelines for the optimization of biologic
therapies for health professionals involved in the management of patients with RA, AS and PsA…

[HTML][HTML] Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry …

…, A Fernández-Nebro, M Rodríguez-Gómez, P Vela… - Medicine, 2015 - journals.lww.com
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple
organ involvement and pronounced racial and ethnic heterogeneity. The aims of the present …

Cardiovascular risk of patients with gout seen at rheumatology clinics following a structured assessment

…, F Sivera, N Quilis, L Carmona, P Vela… - Annals of the …, 2017 - ard.bmj.com
Objectives Gout-associated cardiovascular (CV) risk relates to comorbidities and crystal-led
inflammation. The aim was to estimate the CV risk by prediction tools in new patients with …

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

…, AW Domínguez, JA Mosquera, P Vela… - Annals of the …, 2019 - ard.bmj.com
Objective Psoriatic arthritis (PsA) is a chronic inflammatory arthritis affecting up to 30% of
patients with psoriasis (Ps). To date, most of the known risk loci for PsA are shared with Ps, and …